Exercise Training in Patients with Chronic Respiratory Diseases: Are Cardiovascular Comorbidities and Outcomes Taken into Account?—A Systematic Review

Exercise Training in Patients with Chronic Respiratory Diseases: Are Cardiovascular Comorbidities and Outcomes Taken into Account?—A Systematic Review

Patients with chronic obstructive pulmonary disease (COPD), asthma and interstitial lung diseases (ILD) frequently suffer from cardiovascular comorbidities (CVC). Exercise training is a cornerstone intervention for the management of these conditions, however recommendations on tailoring programmes t...

Full description

Bibliographic Details
Main Authors:	Ana Machado, Kirsten Quadflieg, Ana Oliveira, Charly Keytsman, Alda Marques, Dominique Hansen, Chris Burtin
Format:	Article
Language:	English
Published:	MDPI AG 2019-09-01
Series:	Journal of Clinical Medicine
Subjects:	exercise chronic lung disease chronic obstructive pulmonary disease COPD asthma interstitial lung disease ILD cardiovascular comorbidities cardiovascular outcomes
Online Access:	https://www.mdpi.com/2077-0383/8/9/1458

Similar Items

COMORBIDITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A ROLE OF CARDIOVASCULAR DISORDERS
by: N. A. Karoli, et al.
Published: (2016-01-01)

Impact of coronavirus disease-2019 on chronic respiratory disease in South Korea: an NHIS COVID-19 database cohort study
by: Tak Kyu Oh, et al.
Published: (2021-01-01)

Prospective evaluation of hydroxychloroquine in pediatric interstitial lung diseases: Study protocol for an investigator-initiated, randomized controlled, parallel-group clinical trial
by: Matthias Griese, et al.
Published: (2020-04-01)

Comorbidities of Chronic Obstructive Pulmonary Disease Patients at Respirology and Critical Care Outpatient Clinic Dr. Hasan Sadikin General Hospital, Bandung, Indonesia
by: Adrian Sebastian Suhendro, et al.
Published: (2017-03-01)

Complications in Idiopathic Pulmonary Fibrosis: Focus on Their Clinical and Radiological Features
by: Federica Galioto, et al.
Published: (2020-07-01)

Cardiovascular disease patients have increased risk for comorbidity: A cross-sectional study in the Netherlands
by: Candan Kendir, et al.
Published: (2018-01-01)

Major comorbidities lead to the risk of adverse cardiovascular events in chronic obstructive pulmonary disease patients using inhaled long-acting bronchodilators: a case-control study
by: Yen-Fu Chen, et al.
Published: (2019-12-01)

Prevalence and impact of anemia in patients with chronic respiratory diseases
by: Ali Omar Abdelaziz, et al.
Published: (2018-01-01)

A 2-year-old girl with chronic crackles after respiratory syncytial virus infection: a case report
by: Katarzyna Woicka-Kolejwa, et al.
Published: (2018-09-01)

Comorbidity as a contributor to frequent severe acute exacerbation in COPD patients
by: Jeong SH, et al.
Published: (2016-08-01)

Hospitalisation patterns of patients with interstitial lung disease in the light of comorbidities and medical treatment – a German claims data analysis
by: Julia Wälscher, et al.
Published: (2020-03-01)

Diagnostic yield and risk/benefit analysis of trans-bronchial lung cryobiopsy in diffuse parenchymal lung diseases: a large cohort of 699 patients
by: Claudia Ravaglia, et al.
Published: (2019-01-01)

In Patients with Mild-to-Moderate COPD, Tobacco Smoking, and Not COPD, Is Associated with a Higher Risk of Cardiovascular Comorbidity
by: Soumagne T, et al.
Published: (2020-07-01)

Prevention and treatment of chronic respiratory diseases in China
by: Nan-Shan Zhong, et al.
Published: (2019-12-01)

Increased risk of community-acquired pneumonia in COPD patients with comorbid cardiovascular disease
by: Lin SH, et al.
Published: (2016-12-01)

Longitudinal Imaging Using PET/CT with Collagen-I PET-Tracer and MRI For Assessment of Fibrotic And Inflammatory Lesions In A Rat Lung Injury Model
by: Irma Mahmutovic Persson, et al.
Published: (2020-11-01)

Successful treatment with afatinib following the failure of osimertinib rechallenge with osimertinib-induced interstitial lung disease: A case report
by: Yozo Sato, et al.
Published: (2021-01-01)

Management and Prognosis of Interstitial Lung Disease With Lung Cancer (ILD-LC): A Real-World Cohort From Three Medical Centers in China
by: Xie Xiaohong, et al.
Published: (2021-03-01)

Can the municipalities prevent medication of lifestyle related diseases?
by: Mickael Bech, et al.
Published: (2012-07-01)

Spontaneous pneumothorax during nintedanib therapy in patients with systemic sclerosis‐associated interstitial lung disease
by: Toshiyuki Sumi, et al.
Published: (2021-03-01)

Childhood interstitial lung diseases in immunocompetent children in Australia and New Zealand: a decade’s experience
by: Vishal Saddi, et al.
Published: (2017-07-01)

Distribution of COPD Comorbidities and Creation of Acute Exacerbation Risk Score: Results from SCICP
by: Ge H, et al.
Published: (2021-07-01)

Pulmonary Hypertension Due to Common Respiratory Conditions: Classification, Evaluation and Management Strategies
by: Daniel G. Fein, et al.
Published: (2016-08-01)

Exacerbation of connective tissue disease-associated interstitial lung disease due to influenza vaccination
by: Tai Okusaki, et al.
Published: (2021-01-01)

Association of lung function with cardiovascular risk: a cohort study
by: Bin Wang, et al.
Published: (2018-11-01)

Cardiovascular and chronic obstructive pulmonary diseases: pathophysiological processes and treatment tactics
by: L. G. Ambatiello, et al.
Published: (2020-03-01)

Idiopathic and immune‐related pulmonary fibrosis: diagnostic and therapeutic challenges
by: Andrew McLean‐Tooke, et al.
Published: (2019-01-01)

Interstitial lung abnormality (ILA) and nonspecific interstitial pneumonia (NSIP)
by: Takuya Hino, et al.
Published: (2021-01-01)

Comorbidities of COPD in Bulgarian Patients – Prevalence and Association with Severity and Inflammation
by: Stratev Velin, et al.
Published: (2018-03-01)

Early cardiovascular involvement in Chronic Obstructive Pulmonary Disease
by: M. Malerba, et al.
Published: (2016-01-01)

Management of patients with comorbidity during novel coronavirus (COVID-19) pandemic. National Consensus Statement 2020
by: V. B. Grinevich, et al.
Published: (2020-09-01)

Radiologic features of precancerous areas of the lungs in chronic obstructive pulmonary disease
by: Chubachi S, et al.
Published: (2017-05-01)

A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung disease
by: Alyson W. Wong, et al.
Published: (2020-12-01)

COVID-19 and comorbidities: Deleterious impact on infected patients
by: Hasan Ejaz, et al.
Published: (2020-12-01)

Heterozygosity for E292V in <it>ABCA3</it>, lung function and COPD in 64,000 individuals
by: Bækvad-Hansen Marie, et al.
Published: (2012-08-01)

Patient characteristics and outcome of end-stage lung diseases referred for lung transplantation in North India
by: Kuruswamy Thurai Prasad, et al.
Published: (2018-01-01)

Comorbid Conditions in Chronic Obstructive Pulmonary Disease: Potential Therapeutic Targets for Unmet Needs
by: Kazuto Matsunaga, et al.
Published: (2020-09-01)

Impact of Comorbidity Prevalence and Cardiovascular Disease Status on the Efficacy and Safety of Nebulized Glycopyrrolate in Patients with COPD
by: Putcha N, et al.
Published: (2021-04-01)

Comparative efficacy of leukotriene modifier and inhaled corticosteroids in the complex treatment of steroid-naive patients with bronchial asthma combined with chronic obstructive pulmonary disease with neutrophilic type of inflammation
by: Yu. I. Feshchenko, et al.
Published: (2021-07-01)

Clinical Characteristics and Changes of Clinical Features in Patients with Asthma-COPD Overlap in Korea according to Different Diagnostic Criteria
by: Jeong Uk Lim, et al.
Published: (2020-12-01)